Oxalic Acid

Oxalic Acid

SCHEMBL1411080

CCOc1cc2c(cc1OC)C(c1ccc(OC)nc1)=N[C@@H]1CC[C@@H](O)C[C@H]21.O=C(O)C(=O)O

nearest known ligand 0.49

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

OPRM1SLC6A4

The experimentally established mechanism targets of Oxalic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4D Q08499 3/20 0.49
PDE4A P27815 2/20 0.49
PDE4B Q07343 1/20 0.49
PDE4C Q08493 1/20 0.49
PIK3CA P42336 8/20 0.37
MTOR P42345 1/20 0.34
KMT2A Q03164 3/20 0.34
MEN1 O00255 2/20 0.34
PABPC1 P11940 1/20 0.34
FYN P06241 1/20 0.34
PIK3CD O00329 3/20 0.33
PIK3CB P42338 3/20 0.33
PIK3CG P48736 2/20 0.33
KDM4E B2RXH2 1/20 0.33
CYP3A4 P08684 1/20 0.33
PTGDR Q13258 1/20 0.33
PTGDR2 Q9Y5Y4 1/20 0.33
FPR2 P25090 1/20 0.33
RAD52 P43351 1/20 0.33
CHRM1 P11229 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1411657 0.96 PDE4D (0.49) PDE4DPDE4APDE4BPDE4CPIK3CA
SCHEMBL14910606 0.96 PDE4D (0.49) PDE4DPDE4APDE4BPDE4CPIK3CA
SCHEMBL14910607 0.96 PDE4D (0.49) PDE4DPDE4APDE4BPDE4CPIK3CA
Bromide SCHEMBL1411322 0.95 PDE4D (0.48) PDE4DPDE4APDE4BPDE4CPIK3CA
Hydrochloric Acid SCHEMBL1411662 0.95 PDE4D (0.48) PDE4DPDE4APDE4BPDE4CPIK3CA
Fumaric Acid SCHEMBL1411479 0.94 PDE4D (0.48) PDE4DPDE4APDE4BPDE4CPIK3CA
Fumaric Acid SCHEMBL1411483 0.94 PDE4D (0.48) PDE4DPDE4APDE4BPDE4CPIK3CA
Cadaverine Tartrate SCHEMBL1410804 0.94 PDE4D (0.49) PDE4DPDE4APDE4BPDE4CPIK3CA
Cadaverine Tartrate SCHEMBL1410803 0.94 PDE4D (0.49) PDE4DPDE4APDE4BPDE4CPIK3CA
Sulfuric Acid SCHEMBL1411463 0.93 PDE4D (0.49) PDE4DPDE4APDE4BPDE4CPIK3CA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080194587-A1 phosphodiesterase inhibitor; drug for respiratory system disorders NYCOMED GMBH (DE) 2008-08-14 US claimed
US-8829189-B2 Salts of 6-heterocycle substituted hexahydrophenanthridine derivatives TAKEDA GMBH (DE) 2014-09-09 US disclosed
US-8754218-B2 Salts of 6-heterocycle substituted hexahydrophenanthridine derivatives TAKEDA GMBH (DE) 2014-06-17 US disclosed
US-20140039001-A1 NOVEL SALTS OF 6-HETEROCYCLE SUBSTITUTED HEXAHYDROPHENANTHRIDINE DERIVATIVES TAKEDA GMBH (DE) 2014-02-06 US disclosed
EP-2295423-B1 Novel salts of 6-heterocyclyl substituted hexahydrophenanthridine derivatives TAKEDA GMBH (DE) 2013-10-02 EP disclosed
EP-2189454-B1 Novel salts of 6-heterocyclyl substituted hexahydrophenanthridine derivatives TAKEDA GMBH (DE) 2013-09-25 EP disclosed
US-20130096152-A1 NOVEL SALTS OF 6-HETEROCYCLE SUBSTITUTED HEXAHYDROPHENANTHRIDINE DERIVATIVES NYCOMED GMBH (DE) 2013-04-18 US disclosed
US-8354535-B2 Salts of 6-heterocycle substituted hexahydrophenanthridine derivatives NYCOMED GMBH (DE) 2013-01-15 US disclosed
EP-2295423-A1 Novel salts of 6-heterocyclyl substituted hexahydrophenanthridine derivatives Nycomed GmbH (DE) 2011-03-16 EP disclosed
US-20100190818-A1 Novel salts of 6-heterocycle substituted hexahydrophenanthridine derivatives NYCOMED GMBH (DE) 2010-07-29 US disclosed
EP-2189454-A1 Novel salts of 6-heterocyclyl substituted hexahydrophenanthridine derivatives Nycomed GmbH (DE) 2010-05-26 EP disclosed
US-20080194587-A1 phosphodiesterase inhibitor; drug for respiratory system disorders NYCOMED GMBH (DE) 2008-08-14 US disclosed